Naomi DL Fisher is faculty for Harvard Catalyst’s Postgraduate Education. She is an associate professor of medicine at Harvard Medical School, and director of hypertension services and hypertension innovation at Brigham and Women’s Hospital. Fisher is an endocrinologist with clinical and research expertise in hypertension. She has conducted dozens of clinical research trials at Harvard University, focusing on cardiovascular endocrinology. Her areas of research expertise also include renal denervation, cuffless blood pressure measurement, renal vascular hemodynamics, diabetes, and flavanols. Her bibliography includes original scientific reports, clinical guidelines, reviews, chapters, and online resources.
Fisher is an expert in the field of renal denervation (RDN). She served as principal investigator for the RADIANCE-HTN trials with ultrasound-based RDN for mild, moderate, and resistant hypertension, and she is the national co-PI of the RADIANCE-HTN RDN Continued Access Protocol. She directs the Harvard Catalyst courses How to Design a Clinical Study and Effectively Communicating Research. She received her bachelor’s degree from Princeton University, her MD from the University of Pennsylvania, and completed her residency at Massachusetts General Hospital.